CLP subsidiary awaits approval for gas power projects in Queensland

The projects would increase the Australian state’s generation capacity by a total of more than 20%.

CLP Holdings said its wholly-owned subsidiary TRUenergy is seeking development approval for two high-efficiency gas-fired power stations in Queensland to meet forecast increases in electricity demand.

“The two power plants will be developed in Ipswich, close to the projected population growth areas of southeast Queensland, and in Gladstone in central Queensland, which is projected to be a major hub for industrial growth,” said CLP in an announcement.

Construction could begin as early as 2013, with the permitting process happening over the next 12 months. The power stations will be developed in stages to match the growth in electricity demand. CLP said each project will have an initial size of around 500MW, with a capacity of up to 1500MW.

Follow the link for more news on

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare